Levetiracetam for Benign Rolandic Epilepsy

• Status: Completed
• Trial end date: 2006-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is designed to test if the language problems commonly seen in children with benign rolandic epilepsy would improve by switching anticonvulsants to levetiracetam.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Johns Hopkins University
• Collaborator: UCB Pharma
• Treatments: Etiracetam; Levetiracetam; Piracetam

Criteria

Inclusion Criteria:

• Ages 6-12

• Benign rolandic epilepsy

• Language difficulties as reported by parents or teachers

• On another anticonvulsant other than levetiracetam

Exclusion Criteria:

• Prior use of levetiracetam

• On 2 or more anticonvulsants

• Language problems prior to epilepsy

• Another seizure disorder

• Status epilepticus within the past 6 months

• Significant psychiatric disease

• Progressive neurologic disease